Top Breaking News | More News | Featured Stories | News By Subject | Event News | Investor News | News Archive | Search News
Get Our FREE
Industry eNewsletter
email:    

Investor News

Clinical Development News
Pre-Clinical
IND
Phase I - Safety
Phase II - Safety and Efficacy
Phase III - Controlled Safety and Efficacy
BLA/NDA/ANDA
PDUFA
Approvable Letters
Approval and Marketing Clearance
Post-Approval
Discontinued
Recalls and Warnings

Deals & Dollars News
Alliances
Earnings Reports
Financial
Investor
Mergers and Acquisitions
Start-Ups

IPO News
IPO


Clinical - Phase III
Birken Announces Positive Results Of Phase 3 Trials With Oleogel-S10 For Accelerated Wound Healing In Patients With Partial Thickness Wounds 9/2/2014 9:36:00 AM
Ampio Pharmaceuticals, Inc. (AMPE) Release: Update On The Phase 3 Multicenter, Double-Blind STEP Study Of Ampion™ For Osteoarthritis Of The Knee 9/2/2014 1:30:35 PM
XBiotech USA, Inc. Halts Cancer Study On Positive Phase 3 Results 9/2/2014 1:11:00 PM
Teva Pharmaceutical Industries Limited (TEVA)’s Reslizumab Delivers Clinically And Statistically Significant Reduction In Asthma Exacerbations In Two Pivotal Phase 3 Studies 9/2/2014 12:37:08 PM
Early Phase 3 Data Suggest Sanofi (France) (SAN.PA), Regeneron Pharmaceuticals, Inc. (REGN) Drug May Halve Heart Risk 9/2/2014 6:27:22 AM
Novartis AG (NVS)'s New Heart Drug Cuts Cardiovascular Death Risk By 20 Percent; "Most Exciting Ever" Med Points To Huge Sales 9/2/2014 5:54:54 AM
Exelixis, Inc. (EXEL) Chops 70 Percent Of Workforce After Prostate Drug Cabozantinib Fails Pivotal Study 9/2/2014 5:46:58 AM
Sophiris Bio Inc. (SPHS) Reports Completion Of Enrollment In The "PLUS-1" Phase 3 Trial Of PRX302 For Benign Prostatic Hyperplasia 9/2/2014 11:04:46 AM
Macrocure (MCUR) Completes Enrollment In Pivotal Phase 3 Clinical Trial Of Curexcell In Diabetic Foot Ulcers 9/2/2014 10:30:21 AM
Hatchtech Announces Successful Phase 3 Study Results For Xeglyze™ Lotion 9/2/2014 9:07:39 AM
San Diego's ACADIA Pharmaceuticals, Inc. (ACAD) Wins FDA Breakthrough Therapy Designation For NUPLAZID™ 9/2/2014 7:40:24 AM
Amgen (AMGN)'s Cholesterol Lowering Drug Succeeds In Phase 3 Trial 8/28/2014 8:54:31 AM
Isis Pharmaceuticals, Inc. (ISIS) Initiates Phase 3 Study Of ISIS-APOCIII Rx In Patients With FCS 8/28/2014 11:34:02 AM
FDA Grants Amgen (AMGN) Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 8/27/2014 8:03:55 AM
RedHill Biopharma Ltd. (RDHL) Provides Update On Expansion Of Ongoing RHB-105 Phase 3 Study, Targeting Broadened H. Pylori Indication Authorized By FDA 8/27/2014 7:45:56 AM
1234567
//-->